Corticosteroids in ARDS. An evidence-based review (Q34575310)

3 August 2017

1 reference

title

Corticosteroids in ARDS. An evidence-based review (English)

1 reference

acute respiratory distress syndrome

3 August 2017

main subject

1 reference

John M Luce

1

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

published in

Critical Care Clinics

1 reference

3 August 2017

volume

18

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

79-89, vii

1 reference

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Acute respiratory distress in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

From mega to more reasonable doses of corticosteroids: a decade to recreate hope

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Acute respiratory distress syndrome. Potential pharmacologic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Established ARDS treated with a sustained course of adrenocortical steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Clinical risks for development of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Effectiveness of betamethasone in management of severe infections. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Corticosteroid therapy in severe illness

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Steroid controversy in sepsis and septic shock: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The cardiopulmonary response to massive doses of steroids in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Corticosteroids in septic shock: resurrection of the last rites?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Thirty years of clinical trials in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Clinical predictors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Cortisol response to corticotropin and survival in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Steroids in the treatment of clinical septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Early steroid therapy for respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

Methylprednisolone for unresolving ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900066-6

7 January 2021

10.1016/S0749-0704(03)00066-6

Identifiers

DOI

1 reference

release_mzikoxz2b5grjhm3hdl3qjhh2i

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mzikoxz2b5grjhm3hdl3qjhh2i

24 November 2022

mapped directly with Wikidata item

1 reference